Phenex is a world-renowned drug discovery and development company focused on the target class of nuclear receptors for the development of novel pharmaceuticals.
Location: Germany, Baden-Württemberg, Heidelberg
Total raised: $7.91M
Investors 1
| Date | Name | Website |
| - | Creathor V... | creathor.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 21.09.2010 | Series C | $7.91M | - |
Mentions in press and media 7
| Date | Title | Description | Source |
| 21.04.2017 | Gilead’s billion-dollar NASH acquisition takes some positive... | It’s an early win for a drug Gilead acquired from Nimbus Therapeutics in April 2016. A handful of ot... | medcitynew... |
| 05.01.2017 | Gilead tosses $100M milestone chip in its fast-growing ga... | Almost two years to the day since Gilead $GILD struck a deal worth up to $470 million for Phenex’s... | endpts.com... |
| 21.09.2010 | Phenex Raises €6M in Series C Financing | Phenex Pharmaceuticals AG, a Ludwigshafen, Germany-based drug discovery and development company, clo... | finsmes.co... |
| - | Phenex receives $100 million milestone payment from Gilead | Ludwigshafen, Germany, January 06, 2017 – Phenex Pharmaceuticals AG (Phenex) yesterday announced tha... | creathor.c... |
| - | Creathor invests in Acousia Therapeutics to fight hearing lo... | Creathor Ventures announced today that it has, together with other investors, invested close to EUR ... | creathor.c... |
| - | Gilead’s billion-dollar NASH acquisition takes some positive... | While a Phase 2 trial powers on, Gilead Sciences has announced some earlier proof-of-concept data fo... | medcitynew... |
| - | Phenex announces milestone payment from Janssen | Phenex drug discovery has now resulted in two clinical stage programs this year through research col... | creathor.c... |